RESEARCHERS from Griffith University's Institute for Glycomics have developed a new malaria vaccine and demonstrated that it works in early trials in humans.
Lead researcher Professor Michael Good had so much faith in the vaccine, called PlasProtecT, that he chose to become the first person to receive it.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Mar 17
